Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Chengchuang Blue Ocean Pharmaceutical Technology is a comprehensive pharmaceutical research and development company based in Jinan, China. As a core R&D subsidiary of the Lunan Pharmaceutical Group, the company focuses on the discovery and development of innovative small molecule drugs and high-end generic medications. Its technical capabilities cover the entire drug development chain, including medicinal chemistry, formulation development, clinical trial management, and regulatory registration. The company operates as a Contract Research Organization (CRO) while also driving the internal pipeline for its parent group. Key therapeutic areas of focus include gastroenterology, cardiovascular diseases, oncology, and metabolic disorders. Chengchuang Blue Ocean is instrumental in Lunan's strategic shift toward innovation, leveraging advanced platforms for consistency evaluation and novel drug delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 山东诚创蓝海医药科技.